Fintel experiences that on May 5, 2023, HC Wainwright & Co. maintained protection of Bausch + Lomb (NYSE:BLCO) with a Buy suggestion.
Analyst Price Forecast Suggests 23.46% Upside
As of April 24, 2023, the common one-year price target for Bausch + Lomb is 21.61. The forecasts vary from a low of 17.17 to a excessive of $31.50. The common value goal represents a rise of 23.46% from its newest reported closing value of 17.50.
See our leaderboard of companies with the biggest value goal upside.
The projected annual income for Bausch + Lomb is 3,940MM, a rise of three.41%. The projected annual non-GAAP EPS is 1.05.
What is the Fund Sentiment?
There are 130 funds or institutions reporting positions in Bausch + Lomb. This is a rise of 11 proprietor(s) or 9.24% within the final quarter. Average portfolio weight of all funds devoted to BLCO is 0.37%, a lower of 6.19%. Total shares owned by establishments elevated within the final three months by 4.13% to 47,846K shares. The put/call ratio of BLCO is 0.79, indicating a bullish outlook.
What are Other Shareholders Doing?
Goldentree Asset Management holds 6,328K shares representing 1.81% possession of the corporate. In it is prior submitting, the agency reported proudly owning 6,753K shares, representing a lower of 6.70%. The agency elevated its portfolio allocation in BLCO by 14.98% over the past quarter.
Eminence Capital holds 4,207K shares representing 1.20% possession of the corporate. In it is prior submitting, the agency reported proudly owning 3,663K shares, representing a rise of 12.93%. The agency elevated its portfolio allocation in BLCO by 3.15% over the past quarter.
FIL holds 3,624K shares representing 1.03% possession of the corporate. In it is prior submitting, the agency reported proudly owning 3,623K shares, representing a rise of 0.02%. The agency decreased its portfolio allocation in BLCO by 99.96% over the past quarter.
Icahn Carl C holds 3,500K shares representing 1.00% possession of the corporate. No change within the final quarter.
Norges Bank holds 2,800K shares representing 0.80% possession of the corporate.
See all Bausch + Lomb regulatory filings.
This story initially appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.